Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,526,149
  • Shares Outstanding, K 351,884
  • Annual Sales, $ 8,380 M
  • Annual Income, $ -4,148,000 K
  • 60-Month Beta 0.55
  • Price/Sales 1.05
  • Price/Cash Flow 2.03
  • Price/Book 3.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.06
  • Number of Estimates 8
  • High Estimate 1.34
  • Low Estimate 0.94
  • Prior Year 0.93
  • Growth Rate Est. (year over year) +13.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.56 +8.55%
on 05/02/19
26.79 -8.59%
on 05/08/19
+1.36 (+5.88%)
since 04/18/19
3-Month
22.56 +8.55%
on 05/02/19
26.79 -8.59%
on 05/08/19
+0.98 (+4.17%)
since 02/21/19
52-Week
17.20 +42.38%
on 12/26/18
28.45 -13.92%
on 10/03/18
+2.42 (+10.97%)
since 05/21/18

Most Recent Stories

More News
Is Bausch Health (BHC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

BHC : 24.49 (+1.07%)
All You Need to Know About Bausch (BHC) Rating Upgrade to Buy

Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BHC : 24.49 (+1.07%)
Aerie (AERI) Q1 Earnings Beat, Rhopressa Misses Estimates

Aerie (AERI) reports narrower-than-expected Q1 loss. However, Rhopressa lags expectations.

AERI : 40.86 (+4.37%)
BHC : 24.49 (+1.07%)
PFE : 41.67 (+0.19%)
BMY : 47.43 (+2.42%)
Options Traders Expect Huge Moves in Bausch Health (BHC) Stock

Investors need to pay close attention to Bausch Health (BHC) stock based on the movements in the options market lately.

BHC : 24.49 (+1.07%)
Bausch's (BHC) Q1 Earnings Beat Estimates, Revenues Miss

Bausch (BHC) Q1 earnings surpass estimates, while revenues miss the same. The increase in guidance was impressive.

RHHBY : 33.0500 (-0.18%)
BHC : 24.49 (+1.07%)
ETON : 7.90 (-0.25%)
BMY : 47.43 (+2.42%)
Bausch Health (BHC) Q1 Earnings Top Estimates

Bausch (BHC) delivered earnings and revenue surprises of 15.73% and -1.19%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

BHC : 24.49 (+1.07%)
What's in the Cards for Bausch Health (BHC) Q1 Earnings?

Investors are looking forward to the performance of Salix and Bausch + Lomb, and other pipeline updates, when Bausch (BHC) reports Q1 results on May 6.

GILD : 66.52 (+1.00%)
MNK : 9.87 (-24.25%)
BHC : 24.49 (+1.07%)
ADRO : 3.22 (-0.62%)
Is Bausch Health (BHC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

BHC : 24.49 (+1.07%)
Dr. Reddy's (RDY) Inks Deal to Acquire Portfolio of 42 ANDAs

Dr. Reddy's (RDY) inks agreement to acquire the yet-to-be-marketed portfolio of 42 non-marketed Abbreviated New Drug Applications (ANDAs) in the United States.

RDY : 38.02 (+2.73%)
MNK : 9.87 (-24.25%)
BHC : 24.49 (+1.07%)
EVOK : 0.60 (+1.00%)
Is Bausch Health (BHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

BHC : 24.49 (+1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade BHC with:

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

2nd Resistance Point 24.85
1st Resistance Point 24.67
Last Price 24.49
1st Support Level 24.18
2nd Support Level 23.87

See More

52-Week High 28.45
Last Price 24.49
Fibonacci 61.8% 24.15
Fibonacci 50% 22.83
Fibonacci 38.2% 21.50
52-Week Low 17.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar